Review: Studies on the cardiovascular effects of selective COX-2 inhibitors show mixed results

Belknap, Steven
March 2002
ACP Journal Club;Mar/Apr2002, Vol. 136 Issue 2, p53
Academic Journal
Focuses on a study which investigated the effect of rofecoxib or celecoxib on the risk of arthritis patients to cardiovascular events. Methodology of the study; Results; Comments on the outcome of the study.


Related Articles

  • Task force proposes cardiovascular risk screening. Siddall, Rhonda // British Journal of Hospital Medicine (17508460);Aug2008, Vol. 69 Issue 8, p440 

    The article reports on the proposal of the European Congress of Rheumatology (EULAR) task force on cardiovascular risk that patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis should undergo cardiovascular risk management. Cardiovascular risk calculators such as...

  • Factors Associated with the Length of Remission of Psoriasis Vulgaris. Coimbra, Susana; Oliveira, Hugo; Figueiredo, Américo; Rocha-Pereira, Petronila; Santos-Silva, Alice // Clinical Drug Investigation;Nov2013, Vol. 33 Issue 11, p855 

    Background: Cardiovascular risk factors are found with significantly high frequency in psoriatic patients. Periods of remission and reactivation of lesions are common in psoriasis. Objective: Considering the association of chronic inflammation with the atherogenic process, we aimed to search for...

  • The Impact of Aching Joints on Cardiovascular Disease.  // Heart Advisor;Oct2013, Vol. 16 Issue 10, p10 

    The article discusses the link between inflammatory diseases and increased risk of cardiovascular disease in patients with rheumatoid arthritis (AR). It reflects on a study published at the February 2003 issue of "Circulation" journal which reveals an increasing risk of myocardial infarction in...

  • Rheumatoid arthritis is an independent risk factor for increased carotid intima-media thickness: impact of anti-inflammatory treatment. Ristić, Gorica G.; Lepić, Toplica; Glišić, Branislava; Stanisavljević, Dejana; Vojvodić, Danilo; Petronijević, Milan; Stefanović, Dušan // Rheumatology;Jun2010, Vol. 49 Issue 6, p1076 

    Objectives. To evaluate the extent of subclinical atherosclerosis in patients with RA and low cardiovascular risk by measuring intima-media thickness (IMT) of the carotid arteries and to determine factors associated with increased IMT.

  • Cardiovascular Risk in Patients with Psoriatic Arthritis. Zhu, Tracy Y.; Li, Edmund K.; Lai-Shan Tam // International Journal of Rheumatology;2012, p1 

    Psoriatic arthritis (PsA) is an inflammatory arthritis associated with psoriasis. In addition to skin and joint involvement, there is increasing evidence suggesting that patients with PsA also have an increase in risk of clinical and subclinical cardiovascular diseases, mostly due to...

  • The correlation between cardiovascular risk and functional disability and disease activity in patients with rheumatoid arthritis. GÜLER, Mustafa; YAZGAN UMUT, Saadet; AYDIN, Teoman; REZVANİ, Aylin; POYRAZ, Emine // Turkish Journal of Medical Sciences;2013, Vol. 43 Issue 6, p919 

    Aim: To determine the cardiovascular risk (CVR) in patients with rheumatoid arthritis (RA) and its correlation with disease activity and functional ability by using the Framingham risk score (FRS) and to compare the CVR of the RA patients with the control group with the help of the FRS....

  • Rheumatoid Arthritis Patients at Increased Risk for Cardiovascular Disease.  // O&P Business News;2/1/2008, Vol. 17 Issue 3, p62 

    The article focuses on research that investigated the risk of cardiovascular disease on patients diagnosed with rheumatoid arthritis (RA). According to the study, patients with RA are at an increased risk of developing cardiovascular disease. Further, senior author of the study Sherine Gabriel...

  • Prevalence of cardiovascular risk factors in patients with psoriatic arthritis. Khraishi, Majed; Aslanov, Rana; Rampakakis, Emmanouil; Pollock, Clare; Sampalis, John // Clinical Rheumatology;Oct2014, Vol. 33 Issue 10, p1495 

    Psoriatic arthritis (PsA) is a chronic T cell-mediated inflammatory spondyloarthropathy affecting 10-40 % of psoriasis (PSO) patients (0.3-1.0 % of the general population). Recent epidemiological studies have shown an increased prevalence of cardiovascular (CV) risk factors and/or morbidity...

  • CV Risk Persists in RA Patients despite Increased Medication Use for Both. Hand, Larry // MD Conference Express;Aug2013, Vol. 13 Issue 8, p7 

    Risk of cardiovascular disease\in patients with rheumatoid arthritis persisted at similar rates at 3- and 10-year follow-ups, despite the increased use of statins, antihypertensive agents, and tumor necrosis factor-blocking agents, according to a 10-year prospective study. This article presents...

  • A comparative study on serum lipoprotein (a) and lipid profile between rheumatoid arthritis patients and normal subjects. Govindan, K. P. Shiva; Basha, Saleem; Ramesh, V.; Kumar, C. Naveen; Swathi, S. // Journal of Pharmacy & Bioallied Sciences;2015 Dental Supplement 1, Vol. 7, pS22 

    Background: Rheumatoid arthritis is a chronic and systemic inflammatory disorder, in which Lipoprotein (a) [Lp (a)] increases plaque formation and thus promotes atherosclerosis. Coronary artery disease is one of the co-morbidity in rheumatoid arthritis patients. Aim: The aim of this study is to...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics